Skip to main content

9 Result(s)

within T V Kourelis Remove this filter

and

  1. No Access

    Article

    Natural history of t(11;14) multiple myeloma

    Translocation (11;14) on interphase fluorescent in situ hybridization in plasma cells is regarded as a standard risk prognostic marker in multiple myeloma based on studies conducted before introduction of current...

    A Lakshman, M Alhaj Moustafa, S V Rajkumar, A Dispenzieri, M A Gertz, F K Buadi… in Leukemia (2018)

  2. No Access

    Article

    Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival

    Autologous stem cell transplantation (ASCT) is an important treatment modality in light chain (AL) amyloidosis. Use of reduced-dose melphalan conditioning is common, given the associated organ and functional d...

    N Tandon, E Muchtar, S Sidana, A Dispenzieri, M Q Lacy… in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

    The significance of interphase fluorescence in situ hybridization (iFISH) by regimen type was assessed in 692 immunoglobulin light-chain (AL) amyloidosis patients with iFISH at diagnosis. First-line treatment was...

    E Muchtar, A Dispenzieri, S K Kumar, R P Ketterling, D Dingli, M Q Lacy… in Leukemia (2017)

  4. No Access

    Article

    Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort

    T V Kourelis, A Dispenzieri in Leukemia (2017)

  5. No Access

    Article

    Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

    The presence of high numbers of circulating clonal plasma cells (cPCs) in patients with smoldering multiple myeloma (SMM), detected by a slide-based immunofluorescence assay, has been associated with a shorter...

    W I Gonsalves, S V Rajkumar, A Dispenzieri, D Dingli, M M Timm, W G Morice… in Leukemia (2017)

  6. No Access

    Article

    Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

    Immunoparesis is an adverse prognostic marker in plasma cell proliferative disorders. Its impact in AL amyloidosis has not been explored in depth. Newly diagnosed AL amyloidosis patients (n=998) were evaluated fo...

    E Muchtar, A Dispenzieri, S K Kumar, F K Buadi, M Q Lacy, S Zeldenrust… in Leukemia (2017)

  7. No Access

    Article

    Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

    W I Gonsalves, S V Rajkumar, M A Gertz, A Dispenzieri… in Bone Marrow Transplantation (2016)

  8. No Access

    Article

    Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

    Although clinical improvement is almost universal with therapy in patients with POEMS (an acronym for polyneuropathy, organomegaly, endocrinopathies, monoclonal protein and a variety of skin changes) syndrome,...

    T V Kourelis, F K Buadi, M A Gertz, M Q Lacy, S K Kumar, P Kapoor, R S Go… in Leukemia (2016)

  9. No Access

    Article

    Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma

    T V Kourelis, S K Kumar, G Srivastava, M A Gertz, M Q Lacy, F K Buadi, R A Kyle… in Leukemia (2014)